Junyelt

Copper gluconate, manganese gluconate, potassium iodide, sodium selenite, zinc gluconate, the active ingredients in Junyelt, is a mineral supplement presented as an intravenous solution for intravenous use. It supplies essential trace elements and supports patients with trace element deficiency or those requiring parenteral nutritional support.

GNH USA supplies Junyelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Junyelt provides trace elements for patients with deficiencies and supports metabolic processes that rely on these minerals. - Trace element deficiency: restores adequate copper, manganese, iodine, selenium and zinc levels. - Total parenteral nutrition: complements macronutrient solutions with essential micronutrients. - Post‑operative recovery: aids wound healing and immune function when oral intake is limited. - Chronic dialysis: compensates for losses of trace elements during renal replacement therapy.

Junyelt may cause infusion‑related or systemic reactions.

Common Side Effects: - Infusion site erythema or pain. - Mild nausea or vomiting. - Transient headache. - Low‑grade fever.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Acute copper or zinc toxicity presenting with neurological signs. - Severe electrolyte imbalance (e.g., hyperkalemia). - Renal impairment exacerbation in susceptible patients.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse events. - Assess baseline trace element status: measure serum copper, zinc, selenium, and iodine. - Monitor renal and hepatic function: adjust or discontinue if significant impairment occurs. - Observe for infusion reactions: pause infusion and treat if severe. - Avoid concurrent high‑dose elemental supplements: risk of overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Junyelt can interact with other agents that affect mineral balance or thyroid function.

Major Interactions (Avoid): - High‑dose copper or zinc supplements: increase risk of toxicity. - Iodine‑containing contrast media: may alter thyroid hormone synthesis. - Chelating agents (e.g., penicillamine, dimercaprol): reduce trace element availability.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: monitor thyroid function tests. - Antioxidant vitamins (C, E): may influence selenium utilization.